Mine sisu juurde

chronic lymphocytic leukemia

Lehekülje sisu ei toetata teistes keeltes.

lymphoblastic leukemia characterized by over production of B-cells and their accumulation in bone marrow and blood

Välised allikad

Freebase
LCCN
sh87004460[2]

teema nimetus kujul: Chronic lymphocytic leukemia

Experimental Factor Ontology ID
MeSH descriptor ID
D015451[4]

teema nimetus kujul: Leukemia, Lymphocytic, Chronic, B-Cell

mapping relation type: täpne vaste

Quora topic ID
YSO tunnus
24754[6]

teema nimetus kujul: krooninen lymfaattinen leukemia, kronisk lymfatisk leukemi, chronic lymphoid leukemia

PatientsLikeMe condition ID
KEGG ID
UniProt disease ID
National Cancer Institute ID
DiseasesDB
BBC Things ID
KBpedia ID
internetmedicin.se ID
Orphanet ID
Disease Ontology ID
eMedicine ID
NL CR AUT ID
ph232604

teema nimetus kujul: chronická lymfocytární leukémie

MedlinePlus ID
ICD-O
BabelNet ID
OpenAlex ID
Mondo ID
Human Phenotype Ontology ID
BNF
11944189h[2]

teema nimetus kujul: Leucémie lymphoïde chronique

JSTOR topic ID
ICD-10
WikiSkripta article ID
UMLS CUI
C1868683[15]

mapping relation type: close match

C0855095[15]

mapping relation type: close match

ICD-11 (foundation)
GARD rare disease ID
ICD-11 ID (MMS)
XH15T2

teema nimetus kujul: B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma

BNCF Thesaurus ID
ICD-10-CM
OMIM ID
Encyclopædia Britannica Online ID
topic/chronic-lymphocytic-leukemia

teema nimetus kujul: chronic lymphocytic leukemia

MeSH tree code
Encyclopedia of China (Third Edition) ID
WikiProjectMed ID
National Library of Israel J9U ID

üksikjuht nähtusest

class of disease
symptom or sign

mille alamklass

lymphoblastic leukemia[10]
chronic leukemia
small lymphocytic lymphoma
lümfoom[10]

lühinimi

CLL
KLL

meditsiiniline eriala

hematoloogia

drug or therapy used for treatment

uracil mustard[18]
alemtuzumab[19][20]
mercaptopurine[21]
(RS)-cyclophosphamide[22][20]
chlorambucil[23][20]
pegaspargase[24]
cladribine[25]
ifosfamide[26]
etoposide phosphate[27]
prednisone[20]
bendamustine[20]
(RS)-lenalidomide[20]
pentostatin[20]
nilotinib[20]
pegfilgrastim[20]
doxorubicin[20]
dasatinib monohydrate[20]
ibrutinib[20]
idelalisib[20]
dexamethasone[20]
venetoclax[20]
vincristine[20]
rituximab[20]
ofatumumab[20]
obinutuzumab[20]
chlorambucil[28]

approved by: FDA

algusaeg: 18. märts 1957

(RS)-cyclophosphamide[29]

approved by: FDA

algusaeg: 12. aprill 1960

venetoclax[30]

approved by: FDA

algusaeg: 11. aprill 2016

genetic association

MYNN[31]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

CAMK2D[32]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

CLPTM1L[33]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

POT1[34]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

IRF4[35]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

BAK1[36]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

IRF8[37]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

LEF1[40]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

ACOXL[41]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

FARP2[42]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

HLA-DQA1[43]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

GRAMD1B[44]

määramismeetod: Ülegenoomne assotsiatsiooniuuring, TAS

ARL11[45]
BTK[46]
SF3B1[47]
P53[48]
NOTCH1[49]
BCL2[39]
MYD88[50]
CHD2[51]

Wikimedia projekti fookusnimekiri

ICD-9-CM

204.1[9][15]

ICPC 2 ID

B73

NCI Thesaurus ID

C3163[9]

Commonsi kategooria

Chronic lymphocytic leukemia

teema peakategooria

Category:Chronic lymphocytic leukemia

Viited

  1. Freebase Data Dumps, 28. oktoober 2013
  2. 2,0 2,1 Nuovo soggettario, https://thes.bncf.firenze.sbn.it/termine.php?id=45034, 16. juuni 2021
  3. inferred by common MONDO mappings on source and on Wikidata
  4. Monarch Disease Ontology release 2018-06-29, MONDO_0004948, 28. juuli 2018
  5. Quora
  6. YSO-Wikidata mapping project, 2. veebruar 2022
  7. BBC Things
  8. KBpedia, 9. juuli 2020
  9. 9,00 9,01 9,02 9,03 9,04 9,05 9,06 9,07 9,08 9,09 9,10 9,11 9,12 Disease Ontology, 15. mai 2019, DOID:1040
  10. 10,0 10,1 10,2 10,3 Disease Ontology, 30. november 2020, DOID:1040
  11. BabelNet
  12. 25. jaanuar 2022, 26. jaanuar 2022, https://web.archive.org/web/20220125070108/https://docs.openalex.org/download-snapshot/snapshot-data-format, OpenAlex, https://docs.openalex.org/download-snapshot/snapshot-data-format
  13. OpenAlex, 26. jaanuar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  14. 14,0 14,1 14,2 Human Phenotype Ontology release 2018-03-08, 8. oktoober 2018, HP:0005550
  15. 15,0 15,1 15,2 15,3 15,4 Monarch Disease Ontology release 2018-06-29, 28. juuli 2018, MONDO_0004948
  16. Firenze Keskrahvusraamatukogu
  17. National Library of Israel
  18. N0000146436, 13. detsember 2016, NDF-RT, inglise keel
  19. N0000148705, 13. detsember 2016, NDF-RT, inglise keel
  20. 20,00 20,01 20,02 20,03 20,04 20,05 20,06 20,07 20,08 20,09 20,10 20,11 20,12 20,13 20,14 20,15 20,16 20,17 20,18 Drug Indications Extracted from FAERS, 2. oktoober 2018
  21. N0000147079, 13. detsember 2016, NDF-RT, inglise keel
  22. N0000146452, 13. detsember 2016, NDF-RT, inglise keel
  23. N0000147072, 13. detsember 2016, NDF-RT, inglise keel
  24. N0000148371, 13. detsember 2016, NDF-RT, inglise keel
  25. N0000148293, 13. detsember 2016, NDF-RT, inglise keel
  26. N0000147596, 13. detsember 2016, NDF-RT, inglise keel
  27. N0000148450, 13. detsember 2016, NDF-RT, inglise keel
  28. Inxight: Drugs Database, 2. november 2018, https://drugs.ncats.io/drug/18D0SL7309, http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/010669s032lbl.pdf
  29. Inxight: Drugs Database, 2. november 2018, https://drugs.ncats.io/drug/6UXW23996M, http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012141s090,012142s112lbl.pdf
  30. Inxight: Drugs Database, 2. november 2018, https://drugs.ncats.io/drug/N54AIC43PW, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208573s000lbl.pdf
  31. Phenocarta, A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=55892, http://www.genome.gov/gwastudies/index.cfm?gene=MYNN, 25. mai 2020
  32. Phenocarta, A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=817, http://www.genome.gov/gwastudies/index.cfm?gene=CAMK2D, 25. mai 2020
  33. Phenocarta, A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=81037, http://www.genome.gov/gwastudies/index.cfm?gene=CLPTM1L, 25. mai 2020
  34. Phenocarta, A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=25913, http://www.genome.gov/gwastudies/index.cfm?gene=POT1, 25. mai 2020
  35. Phenocarta, A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=3662, http://www.genome.gov/gwastudies/index.cfm?gene=IRF4, 25. mai 2020
  36. Phenocarta, A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=578, http://www.genome.gov/gwastudies/index.cfm?gene=BAK1, 25. mai 2020
  37. Phenocarta, A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=3394, http://www.genome.gov/gwastudies/index.cfm?gene=IRF8, 25. mai 2020
  38. Phenocarta, Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=596, http://www.genome.gov/gwastudies/index.cfm?gene=BCL2, 25. mai 2020
  39. 39,0 39,1 Open Targets Platform, 24. august 2023, https://platform.opentargets.org/evidence/ENSG00000171791/EFO_0000095, inferred from an Open Targets association score over 0.7
  40. Phenocarta, Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=51176, http://www.genome.gov/gwastudies/index.cfm?gene=LEF1, 25. mai 2020
  41. Phenocarta, Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=55289, http://www.genome.gov/gwastudies/index.cfm?gene=ACOXL, 25. mai 2020
  42. Phenocarta, Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=9855, http://www.genome.gov/gwastudies/index.cfm?gene=FARP2, 25. mai 2020
  43. Phenocarta, Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=3117, http://www.genome.gov/gwastudies/index.cfm?gene=HLA-DQA1, 25. mai 2020
  44. Phenocarta, A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia, https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_1040&ncbiId=57476, http://www.genome.gov/gwastudies/index.cfm?gene=GRAMD1B, 25. mai 2020
  45. Q969Q4, 13. august 2019, UniProt
  46. Open Targets Platform, 24. august 2023, https://platform.opentargets.org/evidence/ENSG00000010671/EFO_0000095, inferred from an Open Targets association score over 0.7
  47. Open Targets Platform, 24. august 2023, https://platform.opentargets.org/evidence/ENSG00000115524/EFO_0000095, inferred from an Open Targets association score over 0.7
  48. Open Targets Platform, 24. august 2023, https://platform.opentargets.org/evidence/ENSG00000141510/EFO_0000095, inferred from an Open Targets association score over 0.7
  49. Open Targets Platform, 24. august 2023, https://platform.opentargets.org/evidence/ENSG00000148400/EFO_0000095, inferred from an Open Targets association score over 0.7
  50. Open Targets Platform, 24. august 2023, https://platform.opentargets.org/evidence/ENSG00000172936/EFO_0000095, inferred from an Open Targets association score over 0.7
  51. Open Targets Platform, 24. august 2023, https://platform.opentargets.org/evidence/ENSG00000173575/EFO_0000095, inferred from an Open Targets association score over 0.7
  52. Identifiers.org, https://registry.identifiers.org/registry/doid